Literature DB >> 21486401

Characteristics of male fertility after renal transplantation.

L G Xu1, Y R Yang, H W Wang, F Qiu, W L Peng, H M Xu, S Han, Y Liu, L G Tang, J Fu.   

Abstract

We investigated factors such as time span between transplantation and having offspring, the dosage of immunosuppressive agents during fertilisation and the effects of fertilisation on recipient's renal allograft function in 212 male recipients registered at eight Chinese organ transplantation centres. Our results are as follows: the 212 male renal allograft recipients conceived with their wives between 15 and 204 months after transplantation. The wives who became pregnant at 15-24 months after the renal transplantation gave birth to a total of 20 babies with an average weight of 3115 ± 517 g, of which 3 (15.0%) were premature. The wives who became pregnant at 25-204 months after the renal transplantation gave birth to a total of 196 babies with an average weight of 3384 ± 438 g, of which 6 (3.1%) were premature. All recipients had normal renal function during the fertile period. In conclusion, the fertility capacity of male renal allograft recipients was associated with the time after transplantation and the dose of immunosuppressive agents used during fertilisation. It might be helpful to have a fertility capacity evaluation before fertilisation. There were no effects of fertility on renal allograft function.
© 2011 Blackwell Verlag GmbH.

Mesh:

Substances:

Year:  2011        PMID: 21486401     DOI: 10.1111/j.1439-0272.2010.01052.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  8 in total

Review 1.  Does Solid Organ Transplantation Affect Male Reproduction?

Authors:  Nannan Thirumavalavan; Jason M Scovell; Richard E Link; Dolores J Lamb; Larry I Lipshultz
Journal:  Eur Urol Focus       Date:  2018-09-05

Review 2.  Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.

Authors:  Loredana Colla; Davide Diena; Maura Rossetti; Ana Maria Manzione; Luca Marozio; Chiara Benedetto; Luigi Biancone
Journal:  J Nephrol       Date:  2018-02-23       Impact factor: 3.902

3.  A prospective study in male recipients of kidney transplantation reveals divergent patterns for inhibin B and testosterone secretions.

Authors:  Safouane M Hamdi; Marie Walschaerts; Louis Bujan; Lionel Rostaing; Nassim Kamar
Journal:  Basic Clin Androl       Date:  2014-06-16

4.  Parenthood and pregnancy in Australians receiving treatment for end-stage kidney disease: protocol of a national study of perinatal and parental outcomes through population record linkage.

Authors:  Erandi Hewawasam; Aarti Gulyani; Christopher E Davies; Elizabeth Sullivan; Sally Wark; Philip A Clayton; Stephen P McDonald; Shilpanjali Jesudason
Journal:  BMJ Open       Date:  2020-05-25       Impact factor: 2.692

Review 5.  Parenthood With Kidney Failure: Answering Questions Patients Ask About Pregnancy.

Authors:  Shilpanjali Jesudason; Amber Williamson; Brooke Huuskes; Erandi Hewawasam
Journal:  Kidney Int Rep       Date:  2022-04-29

Review 6.  Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease.

Authors:  Katarzyna Romejko; Aleksandra Rymarz; Hanna Sadownik; Stanisław Niemczyk
Journal:  Nutrients       Date:  2022-08-21       Impact factor: 6.706

Review 7.  Immunosuppressive drugs and fertility.

Authors:  Clara Leroy; Jean-Marc Rigot; Maryse Leroy; Christine Decanter; Kristell Le Mapihan; Anne-Sophie Parent; Anne-Claire Le Guillou; Ibrahim Yakoub-Agha; Sébastien Dharancy; Christian Noel; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2015-10-21       Impact factor: 4.123

8.  The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.

Authors:  L F Perez-Garcia; R J E M Dolhain; S Vorstenbosch; W Bramer; E van Puijenbroek; J M W Hazes; B Te Winkel
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.